Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: February 2022 News from our Partners at Consultant360

February 2022 News from our Partners at Consultant360

Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Management
Pulmonary arterial hypertension is a rare disorder in which there is high blood pressure in the arteries that bring blood from the right side of the heart to the lungs, usually with idiopathic origins. However, PAH can also be heritable/genetic or associated with other conditions. An estimated 15 to 50 persons per million are affected in the United States.

Alex Rothman, PhD, on the Use of Pulmonary Artery Denervation for PAH Treatment
Is pulmonary artery denervation via a therapeutic intravascular ultrasonic system a safe and effective treatment option for patients with PAH? In this Q& A, Alex Rothman, BM BCh, PhD, highlights what he and his team found through the TROPHY1 study. The research was released in conjunction with ATS 2020 Virtual.

Ryan Tedford, MD, on the Impact of the New PH Definition on Heart Transplant Outcomes
In this podcast, Ryan Tedford, MD, answers our questions about his team's latest study, which assessed the impact of the new definition of pulmonary hypertension (PH) on heart transplant outcomes. Pulmonary artery pressure and survival rates were evaluated.

Expert Conversations: Diagnosis and Management of Acute Pulmonary Embolism
In this podcast, Bhavin Dalal, MD, and Vijay Balasubramanian, MD, talk about controversies in the diagnosis and management of acute pulmonary embolism, including intermediate-risk pulmonary embolism and a need for thrombolysis, and the role of syncope as a manifestation of pulmonary embolism. They also presented on these topics at CHEST 2021 Annual Meeting. 

Expert Conversations: Guidelines on Acute Pulmonary Embolism
In this podcast, Victor J. Test, MD, and Parth Rali, MD, MBBS, talk about controversies in the diagnosis and management of acute pulmonary embolism, including the use of inferior vena cava filters in patients with severe pulmonary embolism and the treatment of patients with intermediate-risk pulmonary embolism.